Thursday, February 2, 2023
wellness India Expo
Home Biotech Vaccines

Vaccines

Latest
Editor’s Zone

The Rising Vaccine Superpower: India’s phenomenal rise in the new vaccine...

Rahul Koul -
454
Biovoice News Vaccine for Dengue
Vaccines

Takeda’s tetravalent vaccine for Dengue approved for use in European Union

BioVoice News Desk -
75
Biovoice News vaccine
Vaccines

Intravacc launches phase I clinical trial of Avacc 10, an intranasal...

BioVoice Correspondent -
61
Vaccines

Takeda’s dengue vaccine candidate granted priority review by US-FDA

BioVoice News Desk -
47
Vaccines

Indian Immunologicals’ FMD Vaccine becomes world’s first animal vaccine to be...

BioVoice News Desk -
40
Vaccines

CEPI and SK bioscience partner to advance mRNA vaccine technology

BioVoice News Desk -
56
Vaccines

BV Academia Series: PPP critical to develop indigenous vaccines

BioVoice Correspondent -
226
Vaccines

BV Academia Series: India will remain the global hub for vaccine...

BioVoice Correspondent -
107
Vaccines

Researchers develop VLP-based vaccine candidate for Covid-19

BioVoice News Desk -
41
Vaccines

Panacea Biotec bags US $127.30 million for supply of pentavalent vaccine

BioVoice News Desk -
64
123...30Page 1 of 30

Face to Face

Face to Face

FACE TO FACE: Amol Naikawadi, Joint Managing Director, Indus Health Plus

Rahul Koul -
400
In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Joint Managing Director of Indus Health Plus, Amol Naikawadi shared his...

Chat with BioVoice

R&D

Events

© Copyright © 2022-2025 BioVoiceNews.com All rights reserved.